Ben Whitby
Ben Whitby oversees regulatory affairs at Qredo, a cross chain protocol for asset managers and traders active in the digital asset markets. Ben is a regulatory conduct and financial crime-crypto specialist focused on shaping and delivering industry solutions, business change and growth through strategic positioning due to regulatory changes and leading edge technology solutions. In addition, Ben is an Advisor for Attestant, a firm that provides Ethereum 2 staking as a service, giving customers the ability to stake their Ether using Attestant’s infrastructure while always retaining full control of their assets. Ben specializes in design authority, governance & oversight, regulator impact assessment, business strategy & process, information management, enterprise deployment, and programme management.
Ben Whitby Professional Experience / Academic History
Professional Experience
-
Contributor, DeFiProjects - Compliance, FATF Travel Rule, Stablecoins
-
Regulatory Conduct and Financial Crime Specialist
-
Governance, Risk and Compliance
CURRENT AFFILIATIONS
EARLY CAREER
He was a Consultant for Medley Business Solutions, where his clients included Network Rail, Defra, DfT, SRA, and Aventis Pharma.
He was a Consultant for Rubus Alumni, where his clients included Cazenove, Aon, Swapstream, 3, and Marks and Spencer.
He was also a Technologist for Monolith and an Analyst for Lloyds of London.
MEDIA
Ben has appeared as a guest on Real Vision.
INTERESTS
Regulation for the token economy, DeFi, crypto assets blockchain, Ethereum and ERC20
MiCA, digital identity, Gov.uk/verify, EiDAS, self sovereign identity
Next Gen AML and Sanctions
MiFID2 and MiFIR (including MAD/R)
Blockchain, DLT and CryptoCurrencies Regulations including uses for Bitcoin and other tokens
Anti Money Laundering Directive 4 and OFAC/FATF recommendations
Tax Transparency and FATCA
EU Capital Markets Union (CMU)
Payments Services Directive 2 PSD2
Dodd Frank Act (esp Titles 7, 8 and Volcker Rule)
Continued focus on international equivalence around G20 outcomes
EU OTC Reform (EMIR) and Central Counterparty Clearing (CCP)
Basel 3 (CRD 2,3 & 4)
Liquidity Risk Standards and ILAS assessment (ILAA/ILAS)
Insolvency legislation